The Pentagon’s addition of Alibaba to its list of Chinese military companies rattled investors for less than a day. American depositary receipts fell 0.8% on Monday and recovered 1.5% on Tuesday, a muted round trip that signals the market is not treating the designation as a fundamental threat. The real problems for Alibaba are elsewhere. Here is what investors should actually be watching.
Citi analyst Alicia Yap described the Pentagon listing as unlikely to translate into any revenue or earnings impact, noting that the relatively small share price reaction reflects widespread investor awareness that inclusion on the Defense Department’s procurement list does not result in actual sanctions or affect core business operations. Alibaba has been added to and removed from this list before, and does not have any Pentagon contracts. Baidu and BYD were also designated on Monday and pushed back against the listing in similar terms.
The more pressing concern is Alibaba’s financials. Adjusted earnings before interest, taxes, depreciation, and amortization fell 56% year over year to 76.4 billion Chinese yuan in fiscal 2026 as the company accelerated AI investment. The spending is intentional, but the scale of the EBITDA compression is significant, and investors are questioning how long the company can sustain that level of investment before the bottom line recovers.
A price war with JD.com and PDD is compounding the pressure. The competitive battle for Chinese e-commerce market share is weighing on margins across the sector, and there is no clear sign of a near-term truce. Alibaba’s ADRs have struggled to hold above $120 in recent sessions, and a sustained break below that level could accelerate losses. The stock is down 18% year-to-date through Monday’s close.
The Pentagon list is a headline risk. The AI spending and the e-commerce price war are the real story.
